News On Japan

Kyoto University Confirms Effectiveness of iPS Cell Therapy for Parkinson's Disease

KYOTO, Apr 19 (News On Japan) - A new treatment for Parkinson's disease using iPS cells developed by Kyoto University has shown a certain level of effectiveness in clinical trials.

Parkinson's disease is a difficult neurological disorder caused by a deficiency of dopamine, a chemical that transmits signals in the brain. Symptoms include tremors and slowed movement, and no fundamental cure has been discovered to date.

A research team led by Jun Takahashi at the Kyoto University Center for iPS Cell Research and Application began a clinical trial in 2018, in which dopamine-producing nerve cells derived from iPS cells were transplanted into the brains of seven patients with Parkinson's disease.

The results showed no severe side effects in any of the participants. In six patients, the transplanted cells produced dopamine, and in four of them, motor function improvements were observed.

Looking ahead, a pharmaceutical company based in Osaka plans to apply to the government for approval to manufacture and sell the treatment, aiming for practical implementation.

Parkinson's disease is a progressive neurodegenerative disorder that primarily affects movement. It was first described in detail in 1817 by British physician James Parkinson in his work An Essay on the Shaking Palsy. The condition is characterized by the gradual loss of dopamine-producing neurons in a region of the brain called the substantia nigra. Dopamine is a neurotransmitter that plays a critical role in controlling smooth and coordinated muscle movements.

As dopamine levels decline, patients begin to exhibit motor symptoms such as tremors at rest, muscle rigidity, bradykinesia or slowness of movement, and postural instability. Non-motor symptoms may also occur, including sleep disturbances, mood disorders, cognitive decline, and autonomic dysfunction. The disease typically appears in people over the age of 60, though early-onset forms can occur.

The exact cause of Parkinson's disease remains unclear, but it is believed to involve a combination of genetic and environmental factors. While some rare cases are linked to specific genetic mutations, most cases are idiopathic, with no identifiable cause. Exposure to certain toxins and a history of head trauma have been studied as possible risk factors.

There is currently no cure for Parkinson's disease. Treatments focus on managing symptoms, primarily through medications that either increase dopamine levels or mimic its effects in the brain. The most commonly used drug is levodopa, often combined with other medications to enhance its effectiveness. In more advanced stages, surgical options such as deep brain stimulation may be considered. Research into new treatments, including cell therapy, gene therapy, and neuroprotective strategies, continues to offer hope for improved management and potential breakthroughs.

Source: KTV NEWS

News On Japan
POPULAR NEWS

Nagoya is on the verge of a major transformation. Over the next decade, the cityscape is expected to undergo a dramatic shift as large-scale redevelopment projects reshape its urban core. The focus is on three key districts—Meieki, Sakae, and Kanayama—each developing in a way that highlights its own unique strengths.

Scholars affiliated with the Science Council of Japan formed a symbolic human chain in front of the National Diet building on May 8th, calling for revisions to the government’s proposed reform bill targeting the council’s structure, as deliberations enter their final phase in the Diet.

Across Japan, road collapses have been occurring with increasing frequency, often blamed on aging infrastructure. In one recent incident in Ashioshi, Saitama Prefecture, a truck was swallowed by a gaping sinkhole.

Two men who were arrested for forcibly entering an elementary school in Tachikawa City, Tokyo, and assaulting staff members have been identified as friends of a student's mother. One of the suspects denies the charges, claiming he was only brushing people off after being restrained.

Cherry blossoms have begun to bloom in Wakkanai and Kushiro, marking the near completion of Japan's cherry blossom front for 2025.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

A groundbreaking project to develop the world’s first artificial satellite made of wood is underway in Kyoto, led by astronaut Takao Doi. The initiative is part of a broader push toward environmentally sustainable space exploration.

Sustainable aviation fuel (SAF), made from used cooking oil and other waste materials, has been produced domestically in Japan for the first time and supplied to an aircraft.

The Nuclear Regulation Authority approved a draft review on April 30th confirming that safety measures at Hokkaido Electric Power’s Tomari Nuclear Power Plant Unit 3 comply with the country’s updated safety standards. This effectively clears the unit for restart, making it the 18th reactor at 11 nuclear plants nationwide to pass the review under the new regulatory framework.

Vegetables that were destined for disposal are being given a new purpose as crayons that retain their natural colors and even a faint trace of their original scent.

One of the main attractions at the Osaka-Kansai Expo, the "flying car," experienced an unexpected malfunction, raising concerns about safety and delaying its return to operation.

What does it feel like to have Restless Legs Syndrome? From my own experience, it is like being buried in sand, with a deep, heavy ache that can only be relieved by moving the legs or through constant massage. Resisting the urge to move can trigger a sense of panic, similar to claustrophobia—just when all you want to do is sleep. It’s exhausting, often lasting through the night and into the early morning hours, sometimes even longer.

Organic fluorine compounds known as PFAS—suspected to be harmful to human health—have been detected at concentrations exceeding the national provisional target in rivers and groundwater at 242 sites across 22 prefectures, according to a government survey.

Kyoto University and its research team have revealed that several former employees of Daikin Industries developed lung diseases, potentially linked to exposure to PFAS (per- and polyfluoroalkyl substances), a group of chemical compounds used in industrial manufacturing.